Continuous glucose monitoring systems are real time glucose sensing and monitoring systems that measure and display glucose levels of a patient at regular interval (usually every 5 minutes). The major difference in these systems from conventional blood glucose meters is that these systems measure glucose levels from the patient’s interstitial fluid between the cells of the skin and not the blood stream, thereby avoiding frequent needle pricking to the patient. A typical CGM system comprises a sensor, receiver and a transmitter. The sensor is inserted under the patient’s skin and is attached with an adhesive, the transmitter is attached to the senor which further relays the information to the receiver. The usage of CGM devices is significantly increasing over traditional glucose monitoring devices as these devices are user friendly, provide access to real time values and trend, and provide enhanced accuracy. Increasing incidences of type I diabetes, rising number of obese people and increasing demand for point of care testing are some of the factors that are expected to increase the demand for continuous glucose monitoring systems.
The global continuous glucose monitoring (CGM) devices market was valued at US$ 3,807.3 million in 2018 and is projected to exhibit a CAGR of 24.8% over the forecast period (2019– 2027).
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/57
Global Continuous Glucose Monitoring (CGM) Devices Market: Drivers
Initiatives to boost adoption of CGM devices is expected to propel growth of the global continuous glucose monitoring (CGM) devices market over the forecast period. For instance, in 2016, the American Diabetes Association recommended diabetes education, training on the device, and support to be provided when a CGM is prescribed, to optimize its benefits.
Recent Developments
Major players operating in the global continuous glucose monitoring (CGM) devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2017, Medtronic launched the world’s first Hybrid Closed Loop system- MiniMed 670G for the people suffering from type 1 diabetes.
Global Continuous Glucose Monitoring (CGM) Devices Market: Restraints
Many health insurance plans and Medicare cover most of the costs for diabetes treatments in the U.S., which is the largest market for glucose monitors. However, reimbursement for CGM systems by the government payer organizations or private insurance payers is limited. In a survey conducted by diabetes experts in 2013 in the U.S. stated that only 6% of the patients suffering from type 1 diabetes use CGM device on a regular basis. High cost of the devices and lack of favorable reimbursement policies collectively are the major factors responsible for limited usage of CGM devices.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/57
Covid-19 Impact Analysis:
Launch of patient assistance programs during COVID-19 pandemic is expected to offer lucrative growth opportunities for players in the global continuous glucose monitoring (CGM) devices market. For instance, in April 2020, DexCom, Inc. launched a new patient assistance program that offers two 90-day supply shipments of Dexcom continuous glucose monitoring system supplies and reduces customer cost to US$ 45 per 90-day supply shipment, in order to aid current U.S. customers who have lost insurance due to the COVID-19 pandemic.
Global Continuous Glucose Monitoring (CGM) Devices Market: Competitive Landscape
Major players operating in the global continuous glucose monitoring (CGM) devices market include, Abbott Laboratories, Dexcom, Inc., GE Healthcare, Glycens, Insulet Corporation, Medtronic, plc, Medtrum Technologies, Inc., Microchip Technology Inc., Micron Technology Inc., NXP Semiconductors, Nemaura Medical, Inc., Qualcomm, Senseonics, STMicroelectronics, Tandem Diabetes Care, Taiwan Semiconductor Manufacturing Company Limited, and Texas Instruments Inc.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/57
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Component
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Benefits and Uses
- Regulatory Scenario
- Reimbursement Scenario
- Epidemiology
- PEST Analysis
- Market Share by Competitive Players
- Segment Share by Major Market Players
- Major Market Players- Segment Units (‘000)
- Market Dynamics
- Global Continuous Glucose Monitoring (CGM) Devices Market, By Component, 2016–2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2016–2027
- Segment Trends
- Transmitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
- Receivers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
- Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
- Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/continuous-glucose-monitoring-market-to-reach-us-144-billion-by-2024-879
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837